Envista Holdings Co. (NYSE:NVST) Shares Purchased by Schroder Investment Management Group

Schroder Investment Management Group lifted its holdings in Envista Holdings Co. (NYSE:NVSTFree Report) by 2.2% in the fourth quarter, Holdings Channel reports. The firm owned 844,062 shares of the company’s stock after buying an additional 18,146 shares during the period. Schroder Investment Management Group’s holdings in Envista were worth $20,308,000 as of its most recent SEC filing.

A number of other institutional investors have also recently made changes to their positions in NVST. Nuance Investments LLC lifted its position in Envista by 953.8% during the 4th quarter. Nuance Investments LLC now owns 3,931,054 shares of the company’s stock worth $94,581,000 after acquiring an additional 3,558,031 shares during the period. River Road Asset Management LLC acquired a new stake in Envista during the 4th quarter worth about $54,931,000. Franklin Resources Inc. lifted its position in Envista by 65.3% during the 4th quarter. Franklin Resources Inc. now owns 5,262,092 shares of the company’s stock worth $126,606,000 after acquiring an additional 2,077,786 shares during the period. Norges Bank acquired a new stake in Envista during the 4th quarter worth about $42,874,000. Finally, Public Employees Retirement Association of Colorado lifted its position in Envista by 3,055.6% during the 4th quarter. Public Employees Retirement Association of Colorado now owns 723,841 shares of the company’s stock worth $17,416,000 after acquiring an additional 700,903 shares during the period.

Envista Stock Performance

Shares of Envista stock opened at $18.15 on Tuesday. The company has a debt-to-equity ratio of 0.34, a quick ratio of 1.93 and a current ratio of 2.27. Envista Holdings Co. has a twelve month low of $17.64 and a twelve month high of $36.14. The business has a 50-day moving average price of $19.29 and a 200 day moving average price of $21.68.

Envista (NYSE:NVSTGet Free Report) last announced its quarterly earnings results on Wednesday, May 1st. The company reported $0.26 earnings per share for the quarter, missing the consensus estimate of $0.31 by ($0.05). Envista had a negative net margin of 4.70% and a positive return on equity of 5.84%. The business had revenue of $623.60 million during the quarter, compared to analysts’ expectations of $634.85 million. During the same quarter in the prior year, the firm earned $0.38 EPS. Envista’s revenue for the quarter was down .6% on a year-over-year basis. On average, analysts predict that Envista Holdings Co. will post 1.22 EPS for the current fiscal year.

Analysts Set New Price Targets

NVST has been the subject of a number of research reports. Leerink Partnrs reaffirmed an “underperform” rating on shares of Envista in a research report on Monday, February 26th. Robert W. Baird lowered their price target on Envista from $22.00 to $19.00 and set a “neutral” rating for the company in a research report on Thursday, May 2nd. Needham & Company LLC reiterated a “hold” rating on shares of Envista in a research note on Monday, June 3rd. SVB Leerink assumed coverage on Envista in a research note on Monday, February 26th. They set an “underperform” rating and a $19.00 price objective for the company. Finally, JPMorgan Chase & Co. reduced their price objective on Envista from $29.00 to $23.00 and set an “overweight” rating for the company in a research note on Thursday, May 2nd. Three investment analysts have rated the stock with a sell rating, seven have assigned a hold rating and two have issued a buy rating to the stock. Based on data from MarketBeat.com, Envista currently has a consensus rating of “Hold” and an average price target of $25.86.

Check Out Our Latest Report on NVST

About Envista

(Free Report)

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.

See Also

Want to see what other hedge funds are holding NVST? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Envista Holdings Co. (NYSE:NVSTFree Report).

Institutional Ownership by Quarter for Envista (NYSE:NVST)

Receive News & Ratings for Envista Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envista and related companies with MarketBeat.com's FREE daily email newsletter.